Article

jdsupra.com on 2017-11-20 16:49

Amgen Inc. v. Sanofi (Fed. Cir. 2017)

Last month, the Federal Circuit rendered a decision in Amgen Inc. v. Sanofi that brought clarity to how the Court (and U.S. Patent and Trademark ...

Related news

Amgen Inc. v. Sanofi (Fed. Cir. 2021)jdsupra.com
Bandai-machi , Lower Austria
Juno Therapeutics, Inc. v. Kite Pharma, Inc. (Fed. Cir. 2021)jdsupra.com
Germany , Lower Austria , La Grande
PureCircle USA Inc. v. SweeGen, Inc. (Fed. Cir. 2024)jdsupra.com
Axle , Germany , California
Biosig Instruments, Inc. v. Nautilus, Inc. (Fed. Cir. 2015)jdsupra.com
Long Island , Seattle
Amgen Inc. v. Vidal (Fed. Cir. 2022)jdsupra.com
Merck Sharp & Dohme Corp. v. Hospira, Inc. (Fed. Cir. 2017)jdsupra.com
Manzhouli , Germany , Easton , Tokai-shi , Caracol
The Medicines Company v. Mylan, Inc. (Fed. Cir. 2017)jdsupra.com
Lower Austria
Exergen Corp. v. Kaz USA, Inc. (Fed. Cir. 2018)jdsupra.com
Germany
Adidas AG v. Nike, Inc. (Fed. Cir. 2020)jdsupra.com
Germany
Bayer Healthcare LLC v. Baxalta Inc. (Fed. Cir. 2021)jdsupra.com
Roussel , United States , Lower Austria
Biogen Int'l GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2021)jdsupra.com
Ireland , Huntington Beach
AIA America, Inc. v. Avid Radiopharmaceuticals (Fed. Cir. 2017)jdsupra.com
Yorktowne , Dickinson , United Kingdom , United States , England
Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2019)jdsupra.com
California , United States , Switzerland
Amgen Inc. v. Sandoz Inc. (Fed. Cir. 2023)jdsupra.com
Amgen Inc. v. Apotex Inc. (Fed. Cir. 2016)jdsupra.com
Amgen Inc. v. Coherus BioSciences Inc. (Fed. Cir. 2019)jdsupra.com
California , United States , Switzerland
Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2017)jdsupra.com
Delaware
Amgen Inc. v. Sandoz Inc. (Fed. Cir. 2019)jdsupra.com
California , United States , Switzerland
Pfizer Inc. v. Sanofi Pasteur Inc. (Fed. Cir. 2024)jdsupra.com
New Zealand , Nemours , United States
Antibody Patents Are Not Immune to § 112: Amgen Inc. v. Sanofi, Aventisub LLC jdsupra.com